en

PRODUCT DETAIL

Praluent 300 mg injekčný roztok naplnený v injekčnom pere

Code 6388D
MA number EU/1/15/1031/019
Product Form: sol inj 1x2 ml/300 mg (pero inj.skl.napl. bez akt.tlačidla)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AX Other lipid modifying agents
C10AX14 Alirocumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 19.08.2020
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 14.01.2021
eu-flag.png sk-flag.png